Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma Article

cited authors

  • Reardon, DA; Quinn, JA; Rich, JN; Desjardins, A; Vredenburgh, J; Gururangan, S; Sathornsumetee, S; Badruddoja, M; McLendon, R; Provenzale, J; Herndon, JE; Dowell, JM; Burkart, JL; Newton, HB; Friedman, AH; Friedman, HS

authors

Publication Date

  • October 1, 2005

webpage

published in

category

keywords

  • DNA methylators
  • Phase I study
  • malignant glioma
  • topoisomerase 1 inhibitors

start page

  • 1478

end page

  • 1486

volume

  • 104

issue

  • 7